Skip to content

Upstream Bio, Inc. UPB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-5,176.5%+442pp-5,618.8%-599pp-5,020.1%-555pp-4,464.6%-337pp-4,127.4%-846pp
Net margin-4,719%+307pp-5,026%-659pp-4,366.8%-530pp-3,836.6%-388pp-3,448.7%-799pp
Returns
Return on equity-41.8%-6.4pp-35.4%
Return on invested capital-58.9%+24.4pp-83.2%
Efficiency
Asset turnover0.0×0.0×
Liquidity
Current ratio23.1×-3.0×26.2×-6.5×32.7×-5.6×38.3×-9.2×47.4×+2.8×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$5.60-11.3%$6.31-10.1%$7.02-7.7%$7.60-8.5%$8.31-75.8%
Valuation
Market capitalization$346.11M-40.9%$1.47B+44.7%$1.01B+65.5%$612.71M+86.6%$328.28M-62.7%
Price / sales104.2×-151×514.1×+152×362.3×+137×225×+82.0×143×-229×
Price / book1.1×-0.2×4.3×+1.6×2.7×+1.2×1.5×+0.8×0.7×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Upstream Bio, Inc.'s ratios come from?
Every ratio is computed from Upstream Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.